ICD-10-CM 2027 diagnosis code
E77.1Defects in glycoprotein degradation
E77.1 is a valid, billable ICD-10-CM code for defects in glycoprotein degradation. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.
Looking up by condition? See ICD-10 code for Sialidosis, ICD-10 code for Fucosidosis, ICD-10 code for Mannosidosis, ICD-10 code for Aspartylglucosaminuria.
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About E77.1
E77.1 is the ICD-10-CM diagnosis code for defects in glycoprotein degradation. It belongs to category E77 (disorders of glycoprotein metabolism), block E70-E88 (metabolic disorders) and chapter 4 (endocrine, nutritional and metabolic diseases). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within E77 (disorders of glycoprotein metabolism), E77.1 is specifically for defects in glycoprotein degradation. Related codes cover defects in post-translational modification of lysosomal enzymes (E77.0), other disorders of glycoprotein metabolism (E77.8) and disorder of glycoprotein metabolism, unspecified (E77.9).
It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.
In MS-DRG v44.0, it is part of the grouping logic for DRG 642 (Inborn and Other Disorders of Metabolism, relative weight 1.3219), in MDC 10 (Endocrine, Nutritional and Metabolic Diseases and Disorders), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Before ICD-10, this condition was coded in ICD-9-CM as 271.8 (other specified disorders of carbohydrate transport and metabolism) and 272.7 (lipidoses).
Coding notes
- Aspartylglucosaminuria
- Fucosidosis
- Mannosidosis
- Sialidosis [mucolipidosis I]
Notes that apply from higher levels
Instructions written at a parent level also apply to E77.1.
Broader instructions also apply from E70-E88 Metabolic disorders and Chapter 4: Endocrine, nutritional and metabolic diseases.
Alphabetic index entries
7 entriesTerms in the official ICD-10-CM index that lead to E77.1.
Codes whose notes reference E77.1
- E75Excludes1
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 10 · Endocrine, Nutritional and Metabolic Diseases and Disorders
ICD-9-CM equivalent
Converter →- 271.8Other specified disorders of carbohydrate transport and metabolismapproximate
- 272.7Lipidosesapproximate
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about E77.1
Is E77.1 billable?
- Yes. E77.1 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can E77.1 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict E77.1 as a principal diagnosis.
Is E77.1 a CC or MCC?
- No. E77.1 is neither a CC nor an MCC under MS-DRG v44.0.
What DRG does E77.1 group to?
- E77.1 is used in the MS-DRG v44.0 logic for MS-DRG 642 (Inborn and Other Disorders of Metabolism). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.
What is the ICD-9 code for E77.1?
- The CMS General Equivalence Mappings map E77.1 to ICD-9-CM 271.8 and 272.7.